
Therapeutic Area | MeSH |
|---|---|
| mental disorders | D001523 |
Brand Name | Status | Last Update |
|---|---|---|
| alprazolam | ANDA | 2027-07-31 |
| alprazolam c-iv | ANDA | 2025-06-02 |
| alprazolam intensol | 2006-01-04 | |
| alprazolam odt c-iv | ANDA | 2025-08-22 |
| alprazolam xr | NDA authorized generic | 2011-04-12 |
| gabazolamine | unapproved drug other | 2011-08-18 |
| gabazolamine-0.5 | unapproved drug other | 2011-08-01 |
| niravam | New Drug Application | 2011-04-19 |
| sentrazolam am | unapproved drug other | 2011-08-01 |
| xanax | New Drug Application | 2024-04-15 |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 4 | — | — | — | — | 4 |
| Drug common name | Alprazolam |
| INN | alprazolam |
| Description | Alprazolam is a member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug. It has a role as an anxiolytic drug, an anticonvulsant, a muscle relaxant, a sedative, a GABA agonist and a xenobiotic. It is a triazolobenzodiazepine and an organochlorine compound. |
| Classification | Small molecule |
| Drug class | Benzodiazepine |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2 |
| PDB | — |
| CAS-ID | 28981-97-7 |
| RxCUI | — |
| ChEMBL ID | CHEMBL661 |
| ChEBI ID | 2611 |
| PubChem CID | 2118 |
| DrugBank | DB00404 |
| UNII ID | YU55MQ3IZY (ChemIDplus, GSRS) |






